Table 1 Baseline characteristics of index individuals stratified by sex; Tehran Lipid and Glucose study (TLGS) (1999–2018)
Men n = 1833 | Women n = 1952 | |
|---|---|---|
Continuous variables | ||
Age (years) | 45.8 (12.3) | 39.7 (11.1) |
BMI (kg/m2) | 26.1 (3.7) | 27.6 (4.5) |
Waist circumference (cm) | 89.9 (10.3) | 87.3 (11.6) |
SBP (mmHg) | 119.1 (17.1) | 115.1 (16.9) |
DBP (mmHg) | 77.7 (10.8) | 76.5 (10.3) |
FPG (mmol/L) | 5.07 (0.5) | 4.9 (0.5) |
2 h-PLPG (mmol/L) | 5.8 (1.7) | 6.1 (1.5) |
TG (mmol/L) | 2.1 (1.3) | 1.7 (1.0) |
HDL-C (mmol/L) | 0.4 (0.1) | 0.5 (0.1) |
TG/HDL-C | 5.4 (4.7) | 3.6 (2.9) |
Categorical variables | ||
Spousal diabetes | 157 (8.5) | 215 (11.0) |
SES | ||
< 6 years of schooling | 330 (18.0) | 350 (17.9) |
6–12 years of schooling | 1088 (59.3) | 1175 (60.1) |
> 12 years of schooling | 415 (22.6) | 427 (21.8) |
Family history of diabetes | 457 (24.9) | 538 (27.6) |
Prevalent CVD | 90 (4.9) | 50 (2.6) |
Smoking status | ||
Never | 1005 (54.8) | 1853 (94.9) |
Past | 270 (14.7) | 31 (1.6) |
Current | 558 (30.4) | 68 (3.5) |
Physical activity level | ||
Low physically active | 450 (24.5) | 529 (27.1) |
Lipid-lowering medication use | 35 (1.9) | 45 (2.3) |
Antihypertensive medication use | 72 (3.9) | 107 (5.5) |